In-Depth Rapid Influenza Diagnostics Market Research Report 2026–2035
The global rapid influenza diagnostics market was valued at USD 1.5 billion in 2025 and is projected to reach USD 2.9 billion by the end of 2035, expanding at a CAGR of approximately 8.7% during the forecast period. The market is experiencing consistent growth due to increasing seasonal influenza outbreaks, rising awareness regarding early disease detection, advancements in point-of-care diagnostic technologies, and expanding access to healthcare services.
